Skip to main content
Clinical Cases in Mineral and Bone Metabolism logoLink to Clinical Cases in Mineral and Bone Metabolism
. 2016 May 11;13(1):38–41. doi: 10.11138/ccmbm/2016.13.1.038

Atraumatic intracapsular neck of femur fractures after prolonged bisphosphonate treatment: a new atypical variant?

Sameer Khalid Khan 1,, Terence Savaridas 2, Jennifer S Hemers 3, Zouheir Maarouf 4, Jane M Orgee 5, Michael M Orr 6
PMCID: PMC4869952  PMID: 27252743

Summary

We present 2 cases of elderly females presenting with atraumatic, near-vertical (Pauwells grade 3), intracapsular neck of femur fractures. Following diagnosis of osteoporosis on DEXA scans, they had received alendronic acid for 7 and 10 years respectively. Routine blood tests and serum estimations of calcium, vitamin-D and thyroid-stimulating hormone, done at admission, were within the normal ranges. These patients were managed with a hemiarthroplasty and a dynamic hip screw (DHS) respectively, following discontinuation of bisphosphonates. We present these 2 cases in light of emerging evidence that associates long-term bisphosphonate use with atypical low energy femoral fractures. Only subtrochanteric/diaphyseal fractures have been reported to date. We present a new variant of atypical femoral neck fractures in metaphyseal bone related to prolonged bisphosphonate therapy.

Keywords: atypical hip fractures, intracapsular fractures, bisphosphonates

Introduction

Bisphosphonate-related femoral fractures are increasingly being reported (1, 2). These typically occur with minimal or no trauma in the subtrochanteric or diaphyseal region (3, 4) and are associated with a history of prolonged bisphosphonate therapy and short duration of prodromal thigh pain. The radiological hallmarks include a transverse or short oblique orientation, unicortical break on the lateral (tension) side of the femur, smooth-looking fracture edges and surrounding cortical hypertrophy (1, 3). Available evidence suggests impaired recruitment of osteoblasts and osteoclasts (4), suppressed new bone formation through reduced bone turnover (5), reduced bone remodeling (6, 7), accumulation of microdamage and subsequent crack propagation leading to fracture. To our knowledge, intracapsular fractures have not been previously reported in relation to bisphosphonate therapy. Informed consent was obtained from both patients discussed below.

Case Report

Case 1

A 78-year-old lady noticed severe pain in her right hip on wakening up one morning and was unable to bear weight through this leg. Radiographs showed a displaced intracapsular fracture in the right proximal femur (Figure 1a). This was a near-vertical fracture through the femoral neck (Pauwels grade 3) (8). The neck-shaft angle on the contralateral proximal femur was 125°. Full-length orthogonal views of the right femur did not show further fractures, lytic lesions or diaphyseal stress reactions. She denied any preceeding groin or thigh pain or any recent trauma. She had a diagnosis of osteoporosis confirmed with a DEXA scan seven years previously (T score −5.3 at spine and −3.7 in the femur) and had been on alendronic acid (70mg weekly) since then. She had a low-calcium diet and was previously diagnosed with hyperparathyroidism for which she is not on any treatment. She had never received steroids or long-term antibiotics and had never smoked. Haematological investigations revealed normal full blood count, C-reactive protein and liver function tests, with mildly raised creatinine (Table 1). She had normal serum estimations of adjusted serum calcium, vitamin D (25-hydroxycholecalciferol) and thyroid stimulating hormone (TSH).

Figure 1.

Figure 1

Anteroposterior pelvis radiographs showing near-vertical intracapsular fractures in (a) case 1, (b) case 2.

Table 1.

Blood tests at admission for the presented cases.

Blood test Normal range Case 1 Case 2
Haemoglobin (g/L) 115 – 160 126 131
White blood cells (×109/L) 4 – 11 10.5 11
Neutrophils (×109/L)) 1.8 – 8.0 9.4 8.7
C-reactive protein (mg/L) <5 <3 15
Urea (mmol/L) 2.5 – 7.8 7.6 5.5
Creatinine (μmol/L) 49 – 90 98 56
Adjusted Calcium (mmol/L) 2.1 – 2.6 2.6 2.33
Albumin 35 – 50 44 46
Total Protein 60 – 80 70 75
Alkaline phosphatase 3–150 U/L 108 102
Serum Vitamin D (nmol/L) 25 – 150 46 53
Thyroid stimulating hormone (mU/L) 0.3 – 4.5 0.44 3.83

Estimated glomerular filtration rate (eGFR) 45 ml/min (stage 3 chronic kidney disease)

She received a cemented hemiarthroplasty [45mm Exeter Trauma Stem (ETS), Stryker™ UK Ltd., Newbury, UK]. The resected proximal femur was sent for histopathological examination. The alendronic acid was discontinued post surgery. Further investigations revealed normal serum electrophoresis and light chain quantitation (LCQ) but a mildly elevated parathyroid hormone (PTH) (88; range 15–65 ng/L). Light microscopy of decalcified, HE-stained (haematoxylin and eosin) sections showed disconnected, predominantly thin and partially thick trabecular bone, with necrosis, haemorrhage and acute inflammatory cells, but no features of malignancy or diffuse inflammation (Figure 2). She had routine hip fracture care during her stay on the trauma ward, including ortho-geriatrician-directed medical care and progressive mobilisation by physiotherapists. She was able to ambulate with a frame when discharged to her own home on the 8th post-operative day. She was pain-free and ambulating with a stick when followed up at 6 months.

Figure 2.

Figure 2

Histology slide (case 1) showing thinned trabeculae and normal osteonal structure. Stained with Haematoxylin and Eosin (magnification: 100x).

Case 2

An 84-year-old lady presented to A&E with a three-day history of spontaneously occurring and progressively worsening pain in her left hip. Three hours prior to A&E admission she had felt a ‘crack’ in her thigh and was now unable to bear weight on this leg. Radiographs revealed a minimally displaced intracapsular fracture, which was near-vertical (Figure 1b). The contralateral neck-shaft angle was 125°. She had been diagnosed with osteoporosis on a DEXA scan 15 years earlier and had been on alendronic acid (70mg weekly) for ten years. A repeat DEXA scan 3 years prior to presentation had confirmed continuing osteopenia (T score −2.2 at spine and −1.4 in the left femur). Her other medications included amlodipine and bendroflumethiazide. Routine blood tests at admission (full blood count, urea & electrolytes, etc.) were within normal ranges (Table 1). Her fracture was stabilized with a dynamic hip screw. Histopathological analysis of the reamings from the femoral head showed normal osteonal architecture and lacunar density, with no signs of previous fracture or remodeling (Table 2). The alendronic acid was discontinued and she was discharged home 7 days later. She was ambulating well when reviewed in the fracture clinic 6 weeks later, and radiographs showed callus at the fracture site.

Table 2.

Summarized histopathological analyses in the presented cases.

Histological features Case 1 (resected femoral head and neck) Case 2 (reamings from femoral head and neck)
Trabeculae Partially thinned in the core of the neck, but focally increased thickness at the cortical surface Compressed and fragmented with equal thickness
Bone marrow Unremarkable Unremarkable
Vascularity Unremarkable Unremarkable
Osteonal architecture Normal Normal
Osteoclastic activity None None
Osteocyte lacunar density Normal Normal
Evidence of previous fracturing None None
Evidence of remodeling None None
Evidence of bone necrosis None None
Evidence of malignancy None None

Discussion

We report the first clinical cases and histopathological analyses of intracapsular fractures in relation to prolonged bisphosphonate therapy. Both patients had received alendronic acid (7 and 10 years respectively) for DEXA-confirmed osteoporosis. One patient had prodromal pain, but both fractures were atraumatic. Radiographs showed near-vertical, smooth-looking fracture lines in the femoral neck, starting on the tension side, i.e. the lateral cortex (9). These radiological appearances share some features with the previously reported subtrochanteric fractures. However, our histopathological findings (normal osteonal architecture and osteocyte lacunar density without any features of previous fractures or attempted healing) differ from those reported in the only histological case study to date (10).

The femoral neck has previously been shown to contain significantly less cellular periosteum (due to far fewer osteprogenitor cells) and more mineralizing periosteum compared to the diaphyseal region (11). This renders the femoral neck periosteum thinner and at risk of fracture. It is plausible that the angulation on the femoral neck and its relatively smaller cross-sectional area compared to the diaphysis, could then lead to a much more rapid fracture propagation without remodeling, before prodromal thigh pain becomes established. This could possibly explain the particular fracture orientation observed on the two patients’ radiographs, and the absence of previously reported histological features (12). A differential diagnosis would be the stress fractures reported to occur in femurs with coxa vara (13); however in each case, both hips looked symmetric, the contralateral neck-shaft angles measured more than the conventional cut-off for coxa vara, and the fracture lines were smooth and near-vertical.

Although we cannot establish a direct causal relationship, this case series does suggest a new anatomical variant and adds to the growing body of evidence linking atypical femoral fractures with long-term bisphosphonate therapy. There are no consensus guidelines as yet on the optimal duration of bisphosphonate therapy. We suggest that any patient with prolonged bisphosphonate treatment presenting with thigh pain without a history of trauma, should be promptly investigated radiologically, and the bisphosphonate discontinued until clinical and radiological features of fracture healing are established.

References

  • 1.Neviaser AS, Lane JM, Lenart BA, et al. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346–50. doi: 10.1097/BOT.0b013e318172841c. [DOI] [PubMed] [Google Scholar]
  • 2.Thompson RN, Phillips JR, McCauley SH, et al. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals. J Bone Joint Surg Br. 2012;94:385–90. doi: 10.1302/0301-620X.94B3.27999. [DOI] [PubMed] [Google Scholar]
  • 3.Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91:2556–61. doi: 10.2106/JBJS.H.01774. [DOI] [PubMed] [Google Scholar]
  • 4.Odvina CV, Zerwekh JE, Rao DS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005;90:1294–301. doi: 10.1210/jc.2004-0952. [DOI] [PubMed] [Google Scholar]
  • 5.Bauer DC, Black DM, Garnero P, et al. Change in Bone Turnover and hip, non-spine and vertebral fracture in alendronate-treated women: The Fracture Intervention Trial. J Bone Miner Res. 2004;19:1250–1258. doi: 10.1359/JBMR.040512. [DOI] [PubMed] [Google Scholar]
  • 6.Li J, Mashiba T, Burr DB. Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage. Calcif Tissue Int. 2001;69:281–286. doi: 10.1007/s002230010036. [DOI] [PubMed] [Google Scholar]
  • 7.Allen MR, Burr DB. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment. J Bone Miner Res. 2007;22:1759–1765. doi: 10.1359/jbmr.070720. [DOI] [PubMed] [Google Scholar]
  • 8.Crawford HB. Conservative treatment of impacted fractures of the femoral neck. A report of 50 cases. J Bone Joint Surg Am. 1960;42:471–479. [PubMed] [Google Scholar]
  • 9.Singh M, Nagrath AR, Maini PS. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am. 1970;52:457–67. [PubMed] [Google Scholar]
  • 10.Aspenberg P, Schilcher J, Fahlgren A. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack. Acta Orthop. 2010;81:460–2. doi: 10.3109/17453674.2010.492766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Allen MR, Burr DB. Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone. Bone. 2005;36:311–6. doi: 10.1016/j.bone.2004.10.013. [DOI] [PubMed] [Google Scholar]
  • 12.Kajino Y, Kabata T, Watanabe K, et al. Histological finding of atypical subtrochanteric fracture after long-term alendronate therapy. J Orthop Sci. 2012;17:313–8. doi: 10.1007/s00776-011-0085-8. [DOI] [PubMed] [Google Scholar]
  • 13.Carpintero P, Leon F, Zafra M, et al. Stress fractures of the femoral neck and coxa vara. Arch Orthop Trauma Surg. 2003;123:273–7. doi: 10.1007/s00402-003-0514-z. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cases in Mineral and Bone Metabolism are provided here courtesy of CIC Edizioni Internazionali

RESOURCES